RaySearch Laboratories
ISIN: SE0000135485 | Ticker: RAY | LEI: 549300TYFVYGS0JFWM28
Country: Sweden
RaySearch® is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
Year founded2000
Served areaWorldwide
HeadquartersEugeniavägen 18C, 10430 Stockholm – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 1,284,904,000.00 | 1,744,746,000.00 | 1,875,950,000.00 |
| Noncurrent Assets | N/A | 707,740,000.00 | 1,228,377,000.00 | 1,248,028,000.00 |
| Licences And Franchises | N/A | 809,000.00 | 575,000.00 | 342,000.00 |
| Intangible Assets Under Development | N/A | 486,008,000.00 | 522,534,000.00 | 518,321,000.00 |
| Noncurrent Receivables | N/A | 26,928,000.00 | 10,204,000.00 | N/A |
| Noncurrent Accrued Income Other Than Noncurrent Contract Assets | N/A | N/A | 10,204,000.00 | 54,697,000.00 |
| Deferred Tax Assets | N/A | 7,227,000.00 | 28,525,000.00 | 25,598,000.00 |
| Current Assets | N/A | 577,164,000.00 | 516,369,000.00 | 627,922,000.00 |
| Inventories | N/A | 9,110,000.00 | 29,991,000.00 | 14,091,000.00 |
| Current Trade Receivables | N/A | 156,811,000.00 | 170,591,000.00 | 246,742,000.00 |
| Current Prepaid Expenses | N/A | 37,701,000.00 | 25,675,000.00 | 55,299,000.00 |
| Current Accrued Income Other Than Current Contract Assets | N/A | N/A | 146,771,000.00 | 123,827,000.00 |
| Other Current Receivables | N/A | 37,279,000.00 | 38,027,000.00 | 16,413,000.00 |
| Current Tax Assets Current | N/A | N/A | 2,779,000.00 | 11,282,000.00 |
| Cash and cash equivalents | 113,858,000.00 | 168,746,000.00 | 102,535,000.00 | 160,268,000.00 |
| Equity And Liabilities | N/A | 1,284,904,000.00 | 1,744,746,000.00 | 1,875,950,000.00 |
| Equity | N/A | 694,351,000.00 | 628,312,000.00 | 657,156,000.00 |
| Issued Capital | N/A | 17,141,000.00 | 17,141,000.00 | 17,141,000.00 |
| Retained Earnings | N/A | 684,913,000.00 | 616,632,000.00 | 640,410,000.00 |
| Share Premium | N/A | 1,975,000.00 | 1,975,000.00 | N/A |
| Other Reserves | N/A | -9,678,000.00 | -7,436,000.00 | N/A |
| Additional Paidin Capital | N/A | N/A | 1,975,000.00 | 1,975,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 694,351,000.00 | 628,312,000.00 | 657,156,000.00 |
| Liabilities | N/A | 590,553,000.00 | 1,116,434,000.00 | 1,218,794,000.00 |
| Noncurrent Liabilities | N/A | 162,537,000.00 | 599,680,000.00 | 604,696,000.00 |
| Deferred Tax Liabilities | N/A | 108,749,000.00 | 107,784,000.00 | 106,874,000.00 |
| Other Noncurrent Financial Liabilities | N/A | N/A | 879,000.00 | 743,000.00 |
| Noncurrent Financial Liabilities At Amortised Cost | N/A | 52,909,000.00 | 491,017,000.00 | N/A |
| Other Noncurrent Nonfinancial Liabilities | N/A | 879,000.00 | 879,000.00 | N/A |
| Current Liabilities | N/A | 428,016,000.00 | 516,754,000.00 | 614,098,000.00 |
| Trade And Other Current Payables | N/A | 19,864,000.00 | 48,774,000.00 | N/A |
| Trade And Other Current Payables To Trade Suppliers | N/A | N/A | 48,774,000.00 | 24,030,000.00 |
| Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | N/A | 385,911,000.00 | 511,423,000.00 |
| Current Tax Liabilities Current | N/A | N/A | 3,713,000.00 | 4,980,000.00 |
| Current Financial Liabilities At Amortised Cost | N/A | 92,519,000.00 | 70,381,000.00 | N/A |
| Other Current Nonfinancial Liabilities | N/A | N/A | 7,975,000.00 | 15,358,000.00 |
| Other Current Liabilities | N/A | 11,363,000.00 | 7,975,000.00 | N/A |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | N/A | 70,381,000.00 | 58,307,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 651,612,000.00 | 641,673,000.00 | N/A |
| Revenue From Contracts With Customers | N/A | 641,673,000.00 | 843,648,000.00 |
| Other Income | 18,283,000.00 | 32,779,000.00 | 49,504,000.00 |
| Profit Loss From Operating Activities | -3,466,000.00 | -53,341,000.00 | 42,744,000.00 |
| Finance Income | 2,737,000.00 | 708,000.00 | 1,109,000.00 |
| Finance Costs | 5,749,000.00 | 6,040,000.00 | 11,478,000.00 |
| Profit Loss Before Tax | -6,478,000.00 | -58,673,000.00 | 32,375,000.00 |
| Income Tax Expense Continuing Operations | 2,602,000.00 | -11,358,000.00 | 8,597,000.00 |
| Profit (loss) | -9,080,000.00 | -47,315,000.00 | 23,778,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -9,080,000.00 | -47,315,000.00 | 23,778,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 77,000.00 | 83,000.00 | N/A |
| Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | 23,000.00 | -19,000,000.00 | -11,000,000.00 |
| Other Adjustments For Noncash Items | N/A | 234,223,000.00 | 226,637,000.00 | 296,103,000.00 |
| Other Adjustments To Reconcile Profit Loss | N/A | 137,000.00 | 167,000.00 | N/A |
| Interest Paid Classified As Operating Activities | N/A | N/A | 6,040,000.00 | 11,474,000.00 |
| Interest Received Classified As Operating Activities | N/A | N/A | 708,000.00 | 506,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 28,212,000.00 | -17,648,000.00 | 13,816,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 331,508,000.00 | 238,162,000.00 | 356,777,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 29,712,000.00 | 51,971,000.00 | 43,515,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 195,881,000.00 | 203,251,000.00 | 187,986,000.00 |
| Other Inflows Outflows Of Cash Classified As Investing Activities | N/A | 0.00 | 17,591,000.00 | N/A |
| Cash Flows From Used In Investing Activities | N/A | -225,593,000.00 | -237,631,000.00 | -231,501,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 0.00 | 49,650,000.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 44,025,000.00 | 43,852,000.00 | 57,224,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | 0.00 | 21,268,000.00 | N/A |
| Cash Flows From Used In Financing Activities | N/A | -44,025,000.00 | -72,234,000.00 | -78,492,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 61,890,000.00 | -71,703,000.00 | 46,784,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -7,002,000.00 | 5,492,000.00 | 10,949,000.00 |
| Cash and cash equivalents | 113,858,000.00 | 168,746,000.00 | 102,535,000.00 | 160,268,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 16.06.23 | Johan Löf | Other | Sell | SEK 39,600,000.00 |
| 15.06.23 | Johan Löf | Other | Other | SEK 52,800,000.00 |
| 23.03.23 | Richard Günther Mårder | Other | Buy | SEK 87,927.00 |
| 23.03.23 | Richard Günther Mårder | Other | Buy | SEK 36,900.00 |
| 16.03.23 | Johan Löf och David Hedfors | Other | Sell | SEK 71,927.40 |
| 16.03.23 | Johan Löf och David Hedfors | Other | Sell | SEK 70,511.40 |
| 16.03.23 | Johan Löf och David Hedfors | Other | Sell | SEK 65,731.90 |
| 16.03.23 | Johan Löf och David Hedfors | Other | Sell | SEK 53,990.40 |
| 16.03.23 | Johan Löf och David Hedfors | Other | Sell | SEK 53,535.30 |
| 16.03.23 | Johan Löf och David Hedfors | Other | Sell | SEK 52,868.80 |
SE0000135485
LEI549300TYFVYGS0JFWM28
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.